Founded in 1551, the UNMSM, or San Marcos, is the oldest and largest public university in South America. San Marcos offers 76 Masters degree and 21 Doctoral degree programs in five academic areas: Health Sciences, Humanities, Basic Sciences, Engineering and Business; there are 46 Schools within these five academic areas. The Health Sciences area includes Schools of Medicine, Pharmacy, Midwifery, Nutrition, Veterinary Medicine, Public Health, Nursing, Dentistry, Psychology, Biologic Sciences and Medical Technology.

Funded in part by the Fogarty International Scholar infrastructure awards, Dr. Jorge Alarcón, past Dean of the School of Public Health, has developed a multimedia classroom and epidemiology website that serves as a repository for educational materials for clinical research methods and analysis, a point for training and communication for epidemiologists throughout Peru, and a data collection site for studies of HIV and STD in pregnant women. The renovated wing includes a videoconferencing room and working space for the UW-Peru Global Health Fellows and Scholars and Peruvian epidemiology students. In addition to the Epidemiology Section, the Center has laboratories and clinical space for research and clinical studies in parasitology, bacteriology, virology retrovirology, and immunology.

San Marcos has hosted a UW Fogarty-supported Fellow or Scholar each year since 2004 and has a long history of training the nation’s epidemiologists, with continuing education programs for epidemiologists working for the Ministry of Health throughout Peru. In addition, San Marcos receives funding from the Global Fund for prevention of maternal-child transmission of HIV and is developing a clinical site for NIH-funded HIV and TB research. With the largest Peruvian network of medical subspecialty training programs, and as the largest public university in Peru, San Marcos offers a wide variety of mentoring and clinical research training opportunities in multiple potential disciplines.
In 2014, Dr. Alarcon and colleagues at UNMSM were awarded the first award by the Peruvian government to create a center of excellence in technology, biotechnology and the environment (Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales (CITBM). The UW is a founding partner on this award and will contribute expertise towards research in these areas. Read more…

UPCH is a private non-profit university founded in 1961 with 8 schools providing undergraduate and post-graduate education in medicine, dentistry, public health, nursing, sciences and philosophy, veterinary medicine and zoology, psychology, and education. The School of Public Health (FASPA) at UPCH was founded in 1998 and is the only School of Public Health in Peru. Dr. Patty Garcia, a prior UW AIRTP trainee, was Dean of this School until selected as the Peruvian Minister of Health July 28, 2016. FASPA’s mission is to generate, apply and disseminate knowledge relevant to health promotion, disease prevention and treatment in human populations. FASPA has played a prominent role in training public health officers of the Peruvian Ministry of Health and other official institutions who develop and implement public health policy. The School provides a series of master’s degree programs, diploma and certificate courses and continuing education in health and health administration in Lima and several provinces.

Peru (and Mexico) rank second only to Brazil as the Latin American countries receiving the most NIH funding. This long-standing history of success reflects strong collaborations with other countries and institutions. The UW and UPCH have successfully competed for research and training grants in areas of communicable and noncommunicable diseases – building a collaborative research training partnership for U.S. and Peruvian health scientists. Over the past 20 years, 91 Peruvian Trainees have received public health and biomedical ethics training at the UW, including 21 MPH or PhD degrees, with over 100 joint publications. All have returned to work in Peru in academia, governmental and nongovernmental organizations. Reciprocally, UPCH has trained more than 50 UW medical and public health students through the Fogarty Multidisciplinary International Research Training (MIRT) program, Fogarty FICRS/F Program and Global Health Fellows Program. These training collaborations have resulted in the development of joint UW-UPCH research projects on HIV, STI, TB, HPV and reproductive tract infections (RTI), and research training grants – including an ICOHRTA-AIDS/TB award, a FIRCA award, an HIV Training Program award, an NIH CIPRA award, two Frameworks in Global Health awards, an Innovations in Global Health award, a Bioinformatics award, a GRIP award, Chronic, Non-Communicable Diseases and Disorders Across the Lifespan award, and a Wellcome Trust-funded urban community randomized trial in 20 Peruvian cities. Read more…

Established in 2000, IMPACTA is a nongovernmental organization founded by former UW AIRTP trainee, Dr. Jorge Sanchez, to perform HIV and STD research in Peru. 2006, Dr. Sanchez received NIH funding to establish an IMPACTA Clinical Trials Unit (CTU) with 9 Clinical Research Sites in Peru. These sites are supported by the HIV Vaccine Trials Network (HVTN), HIV Prevention Trials Network (HPTN), Microbicide Trials Network (MTN), and the AIDS Clinical Trials Group (ACTG). IMPACTA also collaborates on the Fogarty-funded Andean CIPRA, the ICOHRTA-AIDS/TB, INSIGHT, and several other NIH-funded projects. The IMPACTA Laboratory has over 2,400 square feet and is equipped to serve both HVTU and HPTU projects, with capacity to perform cultures, HIV and HSV-2 screening by ELISA, HIV detuned ELISA, Western blot confirmation, CD4 count and viral load. Read more…

Founded in 1538, the HNDM was the first public hospital in Peru. Situated in Lima, the hospital currently has 640 inpatient beds and is a national reference center for health and surgical issues of high complexity, including tuberculosis and HIV infections. The infectious diseases ward has isolation wards for patients with tuberculosis, including multi- and extreme drug resistant TB. Computerized tomography and magnetic resonance imaging is available in the hospital. Read more…

The INCN was founded in 1669, as the “Refugio de Incurables,” or refuge for the “incurables.” Patients receiving care at this refuge had medical disorders associated with poverty, psychiatric disease and debilitating neurologic conditions. Over the next three centuries, the Refuge treated an increasing number of people with neurologic ailments and at the turn of the 20th Century came under the direction of a neurologist. In 1975, the complex was renamed the Instituto Nacional de Ciencias Neurológicas and became the national reference center for neurology in Peru. The INCN has over 300 beds, and modern equipment, including a state-of-the-art helicoidal computerized tomography scanner, magnetic resonance imaging, computerized EEG and brain-mapping machines, Doppler ultrasound, and modern neurogenetics and neurocysticercosis diagnosis laboratories. Each year, neurologists evaluate 60-70,000 patients in the outpatient clinics and approximately 2,500 patients receive inpatient care. Read more…

Headquartered in Callao, Perú, NAMRU – 6 was established as a small research detachment in 1983 through an agreement between the Surgeons General of the Peruvian and U.S. Navies, and with the concurrence of the U.S. Department of State and the Peruvian Ministry of Foreign Affairs. The agreement established a cooperative medical research program in Peru to study infectious diseases of mutual interest. Today NAMRU-6 is an organization of over 300 scientists, physicians, and technicians dedicated to the investigation of tropical diseases that threaten the health of people throughout Latin America.

Research at NAMRU- 6 is focused on understanding, and developing protective strategies against infectious diseases affecting uniformed service members and the general population in Peru and throughout Central and South America while enhancing public health capacity through respectful cooperation with our collaborators. Research activities include laboratory, clinical and bioinformatics-based disease epidemiology and novel pathogen discovery. Additionally, NAMRU-6 performs preclinical and clinical research for vaccine testing and evaluation, studies other prevention and treatment modalities, and develops new diagnostic tests and novel insect control measures. NAMRU-6 is actively engaged in a spectrum of academic and technical training programs aimed at enhancing regional health, security, and research capacity.

NAMRU-6 has fixed facilities at three sites in Peru. The main laboratory and detachment administrative headquarters are located on the compound of the flagship Peruvian Naval Medical Center in Callao, the port city adjacent to Lima. A satellite facility is located in the jungle city, Iquitos. The Lima facility consists of two buildings containing over 33,000 square feet of office space, laboratories, and an animal facility. It is one of the most modern research laboratories in South America and includes three Biosafety Level 3 (BSL 3) laboratories, a BSL 3 animal laboratory, and laboratory equipment for conducting flow cytometry, traditional PCR, MassTag PCR, culture, and ELISA. The Iquitos facility is located on the Peruvian Navy’s Iquitos Hospital compound. It is a 5000 square foot laboratory with BSL 2 capabilities. The Puerto Maldonado facility includes a receiving area, two offices, one conference room and kitchenette. Laboratory space includes four separate rooms. Current equipment includes a biosafety cabinet, centrifuge, refrigerator, -20 freezers and a – 80 freezer. The site is equipped with a generator to maintain activities during electrical outages. Read more…